IMPAX PACS在黑龙江省区域化医疗远程会诊中的初步应用

目的:研究黑龙江省不同医疗机构之间新型协同服务模式,加强垦区各级医疗机构的信息化基础建设,建立基于医学影像存档与通信传输系统(Picture Archiving and Communications System,PACS)的数字化医疗区域。方法:将哈尔滨医科大学附属第四医院现有的影像数据归档,集成到IMPAX PACS数据中心(Internet Data Center,IDC),作为整个区域医疗的影像中心。通过IDC交换平台的延伸覆盖,以及医院信息系统(Hospital Information System,HIS)与XERO集成,可经网络调阅IDC中的影像,实现远程影像会诊。结果:建立基于IMPAX PACS的区域医疗;工程覆盖1家省会大医院和垦区2家综合性医院、5家二级医院、11家农场医院,实现联网医院间的影像学远程会诊。结论:PACS区域远程医疗系统的建立为基层百姓就医提供方便,影像学远程会诊可有效避免影像学重复检查,双向转诊、信息共享给患者带来更多的便利和实惠,具有巨大的社会效益。     

基于成本收益分析的生境网络优化——以苏锡常地区白鹭为例

引入经济学成本收益分析方法对于生境网络优化保护具有重要现实意义。以苏锡常地区白鹭生境网络优化为例,通过分别构建研究区生境网络保护成本与提升收益测算体系、模拟多种情景和优化方案、成本收益分析的方法,实现了满足不同约束条件的优化方案。结果表明:(1)最大收益累积情景下的方案在总收益最高的基础上,实现了保护总成本较低的目的;最佳效益累积情景下的方案在研究区土地资源有限和保护总成本最低的基础上,实现了优化成效最佳的目的;(2)最佳效益累积情景下的方案在实现成本最低的基础上,兼顾到了优化成效的最大化,适宜于土地资源稀缺且城市化快速发展地区;(3)有限效益累积情景作为最佳效益累积情景的基本模式,其优化方案在一定范围内可以兼顾到成本较低和成效较高。将经济学与生态学相结合的网络优化方法,综合考虑了研究区的生态、经济和社会等现实因素,极大的提高了网络优化方案操作的可行性,其思路和方法拓展了网络优化研究视角。但诸多实现因素也决定了成本与收益体系的构建还处于不断完善之中。     

甘精胰岛素在2型糖尿病围手术期对血糖控制的有效性、安全性和效益成本分析

目的:比较2型糖尿病围手术期患者使用甘精胰岛素和速效胰岛素控制血糖的有效性、安全性和效益成本分析.方法:对外科系统需要择期或限期手术的2型糖尿病患者随机给予甘精胰岛素组加速效胰岛素类似物或预混胰岛素类似物控制血糖.结果:两组患者达到了类似的空腹血糖控制,但甘精胰岛素组达标率更高、血糖达标时间短以及低血糖反应更少.尽管甘精胰岛素组患者胰岛素成本较高,但其糖尿病相关检查治疗成本、病房成本以及迭标总成本更低.结论:甘精胰岛素加速效胰岛素类似物可有效控制T2DM患者的围手术期血糖,缩短血糖达标时间,减少低血糖发生率低以及降低住院费用.     

宫颈特殊染色技术对子宫颈癌及宫颈上皮内瘤变初筛的临床研究

目的:探讨宫颈特殊染色技术筛查方法对宫颈癌及癌前病变的筛查意义。方法:本研究通过对1963例就诊我院妇科门诊的患者进行宫颈特殊染色检查(FRD),以组织病理学检查结果为标准,分析FRD宫颈特殊染色的临床意义。结果:1963例患者行宫颈特殊染色检查及对初筛阳性患者行阴道镜下活检,根据活检病理结果进行分析,CINI阳性率80.77%℅,CINII81.25%,CINIII100%℅,侵润癌100%,总阳性率90.50%。结论:利用亚甲蓝显色和醋酸白化反应双重定位及指示,不仅可提高宫颈癌及癌前病变的检出率,而且操作简便,判读容易,结果快速,成本低廉。     

影响心脏骤停患者心肺复苏成功率的因素分析

目的:分析我院心脏骤停患者心肺复苏的成功率,并探讨其影响因素。方法:选取198名行心肺复苏的心脏骤停患者为研究对象,实施心肺复苏,并记录患者一般情况、复苏开始时间和地点、复苏过程和复苏结局等多项指标,统计分析复苏效果。结果:1198名患者,72例取得最终复苏成功,心肺复苏成功率为36.4%;2不同年龄(=15.380,P0.001)、基础性疾病(x~2=11.465,P=0.043)、复苏开始时间(x~2=57.968,P0.001)、地点(x~2=61.384,P0.001)患者心肺复苏成功率差异有统计学意义,年龄16~60岁、非心血管疾病、心脏骤停5分钟内、院内开始心肺复苏者成功率较高;3复苏成功者和失败者复苏持续时间(t=-5.961,P0.001)和气道建立时间(t=-4.045,P=0.004)的差异具有统计学意义,成功者复苏持续时间要短于失败者,而气道建立时间要早于失败者。结论:快速建立人工气道,不盲目延长心肺复苏时间,提高心脏骤停患者心肺复苏的成功率。     

早期呼吸支持救治急性中毒所致呼吸衰竭的临床疗效及安全性

目的:探讨急性中毒导致呼衰的患者在其发病早期给予呼吸支持治疗的效果与安全性。方法:回顾性选取2013年9月至2015年9月在我院接受治疗的86例急性中毒性呼衰的患者,分为为试验组和对照组,每组43例。对照组在患者出现呼吸停止5min内实施气管插管通气治疗,试验组在患者尚未出现呼吸停止,还存在部分自主呼吸的情况下,给予早期呼吸支持治疗。对比分析两组治疗效果、呼吸机使用与住院时间、接受通气后并发症情况。结果:试验组研究对象的总有效率(97.67%),与对照组总有效率(58.14%)相比明显较高,差异有统计学意义(x~2=19.5240,P=0.0000)。试验组研究对象的使用呼吸机时间(33.1±5.7)d、住院时间(65.2±8.6)d与对照组使用呼吸机时间(57.3±6.3)d、住院时间(73.7±9.8)d相比明显较短,差异有统计学意义(t=36.09、85.00,P0.05)。试验组患者的并发症发生率(2.33%)与对照组患者(34.88%)相比明显较低,差异有统计学意义(x~2=12.9768,P=0.00032)。结论:发生急性中毒导致呼衰的患者在其发病早期给予呼吸支持治疗的效果显著,可缩短呼吸机使用时间,安全可靠。     

120例胶囊内镜检查的结果分析

目的:对胶囊内镜检查的安全性、检查结果及诊断价值进行讨论分析。方法:对2011年1月~2013年4月在我院进行胶囊内镜检查的120例患者及健康体检者的临床病例资料进行回顾性分析。结果:所有受检者均顺利完成检查,不明原因消化道出血、慢性腹痛及健康查体者的检出率分别为82.76%、59.26%及40.90%,结肠镜检查阴性者中检出结肠息肉4例,肠易激综合征患者中检出小肠器质性疾病4例。结论:胶囊内镜检查安全无痛苦,对于不明原因消化道出血及慢性腹痛患者的诊断优于传统检查方法,对于区分功能性胃肠病及器质性疾病以及小肠疾病的筛查有一定的参考价值。     

两种的晚期胃癌化疗方案的疗效及成本对比研究

目的:运用药物疗效及经济学方法研究CS辅助化疗与ECF化疗方案,进行成本效果对比分析,为临床合理选用胃癌化疗方案提供参考。方法:选择67例中晚期胃癌患者,随机分为A组(CS,32例)组和B组(ECF组,35例),A组给予CS方案辅助化疗,B组给予ECF方案化疗,3个周期为l疗程,均治疗3个疗程后评价治疗效果及副作用,进行成本效果分析。结果:A组与B组治疗效果比较差异无显著性差异(P>0.05),A组治疗的有较低的相关死亡率,但与B组比较差异无统计学意义(3.13%vs8.57%,P>0.05),A组Ⅲ/Ⅳ度中性粒细胞降低(12.56%vs 37.14%)、Ⅲ/Ⅳ度粒细胞减少性发热(3.13%vs 20.0%)、Ⅲ/Ⅳ度口腔粘膜炎(3.13%vs 22.90%)、肾毒性(15.6%vs 37.10%)、严重低钾血症(6.30%vs 40.0%)的发生率均低于B组(P<0.05)。A组成本较高,并且由于成本增加,有较高的成本效益比。结论:CS方案虽然有较好安全性,但因成本增加,有较高的成本效益比,患者应根据经济能力选择合适的治疗方案。     

基于MIT-BIH心律失常数据库的医用生理信号系统的设计

目的:设计一个心电信号研究系统,该系统是远程心电监护仪器研制中的重要组成部分.方法:先用高性能的PC机和高性能的DA转换器搭建一个硬件平台,再以Visual C++6.0为平台,利用面向对象语言编程建立MIT-BIH心电数据库.结果:系统可以对MIT-Bill心电数据库中的心电和呼吸数据进行管理和回放,并建立实验数据平台,来产生模拟的心电、呼吸等生理信号,可用于研发远程心电监护仪器调试使用.结论:可为以后心电信号的研究分析和相关仪器的开发提供了一个优秀的研究平台.     

HPV-DNA 亚型检测联合液基细胞学对宫颈癌 筛查的临床价值

目的:探讨HPV-DNA亚型检测联合液基细胞学对宫颈癌筛查的临床价值.方法:对自愿接受宫颈癌筛查的女性1462例作为研究对象,分别对其进行HPV-DNA亚型检测以及液基细胞学的检查,对于出现阳性的患者进行病理组织学检查.结果:HPV+TCT对宫颈癌早期病变以及癌变的检出率为69.67％明显高于HPV检查的56.28％以及TCT检查的63.89％(P＜0.05);HPV+TCT对GIN Ⅰ、CIN Ⅱ、CINⅢ、癌的检出率分别为91.67％,92.86％、91.67％以及100％.结论:采用HPV-DNA亚型检测联合液基细胞学对宫颈癌筛查,可明显提高其对癌前病变的检出率,是一种高效、简单的检测方法.     

The Effectiveness of Teleglaucoma versus In-Patient Examination for Glaucoma Screening: A Systematic Review and Meta-Analysis

BackgroundGlaucoma is the leading cause of irreversible visual impairment in the world affecting 60.5 million people worldwide in 2010, which is expected to increase to approximately 79.6 million by 2020. Therefore, glaucoma screening is important to detect, diagnose, and treat patients at the earlier stages to prevent disease progression and vision loss. Teleglaucoma uses stereoscopic digital imaging to take ocular images, which are transmitted electronically to an ocular specialist. The purpose is to synthesize literature to evaluate teleglaucoma, its diagnostic accuracy, healthcare system benefits, and cost-effectiveness.MethodsA systematic search was conducted to help locate published and unpublished studies. Studies which evaluate teleglaucoma as a screening device for glaucoma were included. A meta-analysis was conducted to provide estimates of diagnostic accuracy, diagnostic odds ratio, and the relative percentage of glaucoma cases detected. The improvements to healthcare service quality and cost data were assessed.ResultsOf 11237 studies reviewed, 45 were included. Our results indicated that, teleglaucoma is more specific and less sensitive than in-person examination. The pooled estimates of sensitivity was 0.832 [95% CI 0.770, 0.881] and specificity was 0.790 [95% CI 0.668, 0.876]. The relative odds of a positive screen test in glaucoma cases are 18.7 times more likely than a negative screen test in a non-glaucoma cases. Additionally, the mean cost for every case of glaucoma detected was $1098.67 US and of teleglaucoma per patient screened was $922.77 US.ConclusionTeleglaucoma can accurately discriminate between screen test results with greater odds for positive cases. It detects more cases of glaucoma than in-person examination. Both patients and the healthcare systems benefit from early detection, reduction in wait and travel times, increased specialist referral rates, and cost savings. Teleglaucoma is an effective screening tool for glaucoma specifically for remote and under-services communities.     

一种非酒精性脂肪性肝病的超声影像人工智能辅助诊断系统开发

摘要 目的：结合人工智能方法设计针对肝脏超声影像的辅助诊断系统，辅助医生对大样本肝脏超声影像数据的标准化和高效化诊断，实现基于肝脏超声图像的非酒精性脂肪性肝病的精准诊断。方法：通过开发肝脏超声影像的识别与分类、脂肪肝分级分析和肝脏脂肪含量定量分析三个模块，建立一套非酒精性脂肪性肝病的超声影像人工智能辅助诊断系统，该系统能够自动区分输入到系统中不同采样视野的超声影像类型，并对肝脏超声图像进行数字化分析，给出待测超声图像是否呈现脂肪肝以及其肝脏脂肪含量的百分比值。结果：本研究中的超声图像识别分类模块可高通量区分出肝肾比图像和衰减率图像的两类超声影像，其分类的准确率达100%。脂肪肝分级分析模块在测试集数据的准确率达到84%，展现出可胜任辅助医生诊断的能力。基于人工肝脏脂肪含量定量方法开发的肝脏脂肪含量定量分析模块的准确率达到67.74%。结论：本研究已开发出一套基于肝脏超声影像的智能辅助诊断系统，可以辅助医生快速、简单、无创地筛选出潜在患有脂肪肝的患者，虽然现阶段实现肝脏脂肪定量分析仍有难度，但已展现出较大的临床应用潜力。     

Active case detection methods for crusted scabies and leprosy: A systematic review

BackgroundCrusted scabies is endemic in some remote Aboriginal communities in the Northern Territory (NT) of Australia and carries a high mortality risk. Improvement in active case detection (ACD) for crusted scabies is hampered by a lack of evidence about best practice. We therefore conducted a systematic review of ACD methods for leprosy, a condition with similar ACD requirements, to consider how findings could be informative to crusted scabies detection.Methods and principle findingsWe conducted systematic searches in MEDLINE, CINAHL, Scopus and the Cochrane Database for Systematic Reviews for studies published since 1999 that reported at least one comparison rate (detection or prevalence rate) against which the yield of the ACD method could be assessed. The search yielded 15 eligible studies from 511. Study heterogeneity precluded meta-analysis. Contact tracing and community screening of marginalised ethnic groups yielded the highest new case detection rates. Rapid community screening campaigns, and those using less experienced screening personnel, were associated with lower suspect confirmation rates. There is insufficient data to assess whether ACD campaigns improve treatment outcomes or disease control.ConclusionThis review demonstrates the importance of ACD campaigns in communities facing the highest barriers to healthcare access and within neighbourhoods of index cases. The potential benefit of ACD for crusted scabies is not quantified, however, lessons from leprosy suggest value in follow-up with previously identified cases and their close contacts to support for scabies control and to reduce the likelihood of reinfection in the crusted scabies case. Skilled screening personnel and appropriate community engagement strategies are needed to maximise screening uptake. More research is needed to assess ACD cost effectiveness, impact on disease control, and to explore ACD methods capable of capturing the homeless and highly mobile who may be missed in household centric models.     

Evaluation of a colorectal cancer screening program composed of successive waves of different tests: The experience of the French Calvados County

BackgroundsThe value of colorectal cancer (CRC) screening program in a population with a limited participation rate is debated. This study assesses the real-life performances of different screening tests in a population benefiting from an organized program and included in a cancer registry.MethodsPatients who participated in at least one screening campaign between 2004 and 2016 were included. Four screening procedures were used: Hemoccult II, Magstream, Hemoccult and Magstream combined, and OC Sensor. Data were crossed with the Digestive Cancer Registry of Calvados to detect CRCs diagnosed during this period. The main outcomes were CRC detection and the incidence rate of interval cancers.ResultsScreening consisted of 325,083 tests in 134,498 patients. Of the 2580 CRCs detected in patients aged 50–74, 534 (20.7 %) were screen-detected. OC Sensor had the highest sensitivity for CRC detection (83.7 %, 95 % CI [76.8–89.1 %]) and the lowest interval cancer rate (2.0 per 10,000 person-years, 95 % CI [1.4–2.7]) compared with other screening tests, excluding combinations. The overall participation rate was 28.9 %.ConclusionReal-life differences in performance between different screening tests exist, and OC Sensor appears to be the best. The low participation rate suggests that the rate of screen-detected CRC could be higher.     

超声乳化联合房角分离治疗急性闭角型青光眼的临床观察

目的:观察和比较白内障超声乳化吸除人工晶状体植入术联合前房角分离术或小梁切除术治疗原发性急性闭角型青光眼合并白内障的临床疗效。方法:选择哈尔滨医科大学附属第一医院眼科医院2017年1月～2017年11月收治的原发性急性闭角型青光眼合并白内障患者62例,根据手术方式不同将其随机分为A、B两组,A组(31例,行Phaco+IOL联合前房角分离术);B组(31例,行Phaco+IOL联合小梁切除术)。分别观察两组患者术前术后最佳矫正视力(BCVA)、眼压(IOP)、前房深度(ACD)、角膜内皮细胞密度(ECD)的变化。结果:两组患者术后3天、3个月BCVA及IOP和术前比较均明显提高(P0.05),IOP控制至正常范围。且术后1周,A组视力恢复及眼压控制均优于B组(P0.05)。两组患者术后3月,ACD及ECD均较术前明显变化,ACD加深,ECD减少(P0.05),且A组ACD明显高于B组(P0.05)。结论:Phaco+IOL联合前房角分离术治疗急性闭角型青光眼合并白内障患者能有效降低眼压,在早期即可获得较好的临床效果。     

超声造影定量与动态增强MRI定量在宫颈癌诊断中的应用价值

摘要 目的：探究超声造影定量与动态增强MRI定量在宫颈癌诊断中的应用价值。方法：选择2016年1月至2019年1月于我院接受治疗的86例疑似宫颈癌患者为实验组,另选取同期于我院接受治疗的50例宫颈良性病变患者为对照组,分别对两组患者实施超声造影定量检测及动态增强MRI检查,对比两组患者各参数组间差异性,同时以病理学检测结果为金标准,分析两种检查手段对宫颈癌的筛查效果并实施组间比较。结果：（1）比较显示实验组患者的峰值强度（peak intensity,PI）及时间-曲线下面积（area under curve,AUC）均高于对照组,达峰时间（time to peak,TTP）及平均渡越时间（mean transit time,MTT）均低于对照组（P<0.05）;（2）比较显示实验组患者的容积转移常数（volume transfer constant,K ^trans ）、速率常数（rate constant,k _ep ）以及血管外细胞外容积分数（extravascular extracellular volume fraction,V _e ）均高于对照组,表观扩散系数（apparent diffusion coefficient,ADC）低于对照组（P<0.05）;（3）以病理学检测结果为金标准,超声造影定量检测对宫颈癌检测一致性为93.02 %,灵敏度为94.44 %,特异度为85.71 %,增强MRI对宫颈癌检测一致性为96.51%,灵敏度为98.61%,特异度为85.71%。结论：宫颈癌患者实施超声造影定量与增强MRI检测时检测参数与正常宫颈组织相比会出现明显的差异性,可将上述两种检测方式用于宫颈癌患者的筛查诊断中。     

Environmental and economic impact of using new-generation wide-base tires

Purpose

New-generation wide-base tire (NG-WBT) is known for improving fuel economy and at the same time for potentially causing a greater damage to pavement. No study has been conducted to evaluate the net environmental saving of the combined system of pavements and NG-WBT. This study adopted a holistic approach (life cycle assessment [LCA] and life cycle costing [LCC]) to quantitatively evaluate the environmental and economic impact of using NG-WBT.

Methods

The net effect of different levels of market penetration of NG-WBT on energy consumption, global warming potential (GWP), and cost based on the fatigue cracking and rutting performance of two different asphalt concrete (AC) pavement structures was evaluated. The performance of pavements was determined based on pavement design lives; pavement surface characteristics, and pavement critical strain responses obtained from the artificial neural network (ANN) based on finite element (FE) simulations were used to calculate design lives of pavements. Based on the calculated design lives, life cycle inventory (LCI) and cost databases, and rolling resistance (RR) models previously developed by the University of Illinois at Urbana-Champaign (UIUC) were used to calculate the environmental and economic impact of the combined system.

Results and discussion

The fuel economy improvement using NG-WBT is 1.5% per axle. Scenario-based case studies were conducted. Considering 0% NG-WBT market penetration (or 100% standard dual tire assembly [DTA]) as a baseline, scenario 1 assumed the same fatigue and rutting potential between NG-WBT and DTA; therefore, the only difference came from fuel economy improvement of using NG-WBT. In scenario 2, pavement fatigue cracking potential determined the pavement design life; both thick and thin AC overlay sections experienced positive net environmental savings, but mixed net economic savings. In scenario 3, pavement rutting potential determined the pavement design life; the thick AC overlay section experienced positive net environmental savings, but mixed net economic savings. The thin section experienced negative net environmental and economic savings.

Conclusions

The outcomes of scenario-based case studies indicated that NG-WBT can result in significant savings in life cycle energy consumption and cost, and GWP; however, these benefits were sensitive to the method used to determine the pavement performance; especially, a small change in pavement strain can result in significant change in pavement life. In addition, the effect of fuel price/economy improvement, discount rate, and International Roughness Index (IRI) threshold values was studied in the sensitivity analyses.

     

Screening Rate for Primary Aldosteronism Among Patients With Apparent Treatment-Resistant Hypertension: Retrospective Analysis of Current Practice

ObjectivePrimary aldosteronism (PA) is the most common secondary cause of hypertension. Patients with PA experience significant cardiovascular and other complications compared with patients with primary hypertension with the same degree of blood pressure control as those with PA. Guidelines have recommended screening all patients with resistant hypertension for PA. The objective of this study was to assess the screening rate for PA among patients with apparent treatment-resistant hypertension and determine the rate of positive screening test result among the group screened.MethodsThis was a retrospective chart review of electronic medical record data of all patients with hypertension aged ≥18 years within a single health system in Minnesota from September 2018 to September 2020.ResultsOf 140 734 patients who were aged ≥18 years and had a diagnosis of hypertension, 18 908 (13.4%) met the criteria for apparent treatment-resistant hypertension after those with congestive heart failure were excluded. Only 795 (4.2%) patients with apparent treatment-resistant hypertension underwent screening for PA in our cohort. Of the 795 patients who underwent screening for PA, 134 (16.9%) had a positive screening test result.ConclusionThe screening rate for PA among patients with resistant hypertension was low. Clinical and public health strategies directed at improving the screening rate for PA are vital.     

Physician-Reported Barriers to Osteoporosis Screening: A Nationwide Survey

ObjectiveDespite increased awareness, osteoporosis screening rates remain low. The objective of this survey study was to identify physician-reported barriers to osteoporosis screening.MethodsWe conducted a survey of 600 physician members of the Endocrine Society, American Academy of Family Practice, and American Geriatrics Society. The respondents were asked to rate barriers to osteoporosis screening in their patients. We performed multivariable logistic regression analyses to determine correlates with the most commonly reported barriers.ResultsOf 566 response-eligible physicians, 359 completed the survey (response rate, 63%). The most commonly reported barriers to osteoporosis screening included patient nonadherence (63%), physician concern about cost (56%), clinic visit time constraints (51%), low on the priority list (45%), and patient concern about cost (43%). Patient nonadherence as a barrier was correlated with physicians in academic tertiary centers (odds ratio [OR], 2.34; 95% confidence interval [CI], 1.06-5.13), whereas clinic visit time constraints were correlated with physicians in both community-based academic affiliates and academic tertiary care ([OR, 1.96; 95% CI, 1.10-3.50] and [OR, 2.48; 95% CI, 1.22-5.07], respectively). Geriatricians (OR, 0.40; 95% CI, 0.21-0.76) and physicians with >10 years in practice were less likely to report clinic visit time constraints as a barrier (11-20 years: OR, 0.41; 95% CI, 0.20-0.85; >20 years: OR, 0.32; 95% CI, 0.16-0.65). Physicians with more patient-facing time (3-5 compared with 0.5-2 d/wk) were more likely to place screening low on the priority list (OR, 2.66; 95% CI, 1.34-5.29).ConclusionUnderstanding barriers to osteoporosis screening is vital in developing strategies to improve osteoporosis care.     

上海市5家试点医院医疗服务项目成本核算结果分析

目的 对上海市5家试点医院2013年医疗服务项目成本核算结果进行分析,为推进成本核算工作、调整医疗服务项目价格提供参考依据。方法 采用作业成本法作为科室级医疗服务项目成本核算方法、采用加权平均法作为院级医疗服务项目成本核算方法;从收益情况、成本构成以及单位成本与收费价格比较3个方面展开分析。结果 在现行公立医院补偿模式下,医疗服务项目成本无法完全通过医疗服务收费和财政基本支出补助予以弥补,综合医疗服务类、中医类等体现医务人员技术劳务价值的医疗服务项目亏损严重。结论 在确保稳定的前提下,进一步调整医疗服务价格,通过开展成本核算和比价研究,最终建立以成本和收入结构变化为基础的价格动态调整机制。